What researchers gave, and to whom
CJC-1295 amounts and timing from the studies
You’ll see the amounts researchers used and why none of them is a personal plan for your body.
What amounts did the studies use?
CJC-1295 belongs to a drug group called peptides, which are short chains of protein pieces. Researchers gave this drug by shots under the skin. This page lists the figures researchers used; it gives you no dose. No amount has been proved safe and useful for people.
The human studies used one-time shots of 30, 60, or 90 micrograms for every kilogram the person weighed [1][3]. One gram contains a million micrograms. A mouse study used 2 micrograms every 24-, 48-, or 72-hour stretch [7]. The shortest gap restored growth best in those mice, but mice can’t set your care.
Some clinics and posts name 100-300 micrograms for the short 1-29 form or a CJC-1295/ipamorelin pair. The second drug, ipamorelin, is also made from small protein parts. Controlled human trials haven’t backed those amounts for CJC-1295. None is a personal plan for you or accounts for your health and medicines.
How long can CJC-1295 stay in the blood?
The blood protein albumin joins the long form. That link lets CJC-1295 remain there for days. In healthy adults, the body cleared half in about 5.8 to 8.1 days. After more shots, IGF-1, the insulin-like growth factor, was still above its starting level on day 28 [1].
The short 1-29 form lacks the albumin link [2]. The 1-29 name means it copies the first through twenty-ninth protein parts of a natural hormone. Your body removes that form much faster. The form comparison shows why you can’t swap the two timing results.
Is any CJC-1295 dose proved safe for you?
No human dose has been proved safe and useful for CJC-1295. Small studies used one-time 30-90 micrograms per kilogram shots under the skin [1]. They checked hormone levels, not better health over time. An amount posted online can’t tell you what’s safe for your body or how your medicines may affect the risk.
Did studies prove a CJC-1295 DAC dose?
No human dose has been proved for the long form. Its albumin link makes the drug remain in the bloodstream much longer. Studies used one-time amounts of 30, 60, or 90 micrograms per kilogram [1][3]. The body cleared half in about 5.8-8.1 days, so repeat shots could build up unlike the short form [1][2].
Did a trial set a CJC-1295 and ipamorelin dose?
No controlled human study has found an amount for using the CJC-1295/ipamorelin pair. The second drug, ipamorelin, acts on the gland in a different fashion [5]. A lab result can’t give you a safe dose or account for your health. Dosing schedules found online weren’t tested in healthy adults.
Why did CJC-1295 studies use shots instead of pills?
Most CJC-1295 studies used a shot just under the skin [1][2]. Digestion tears apart a swallowed protein chain like this. Researchers therefore used shots, not pills [1]. That tells you what the studies did; it doesn’t direct your care.
Did any study use a vein?
Most researchers put CJC-1295 just below the skin with a shot. Early tests put the short form, called 1-29, into a vein [1][2]. Later work with both forms focused on shots beneath the skin. That history describes the research; it doesn’t tell you what to do with your body.
Why don’t CJC-1295 study details make home use safe?
Study staff measured the powder and mixing water and kept both cold [1]. They used shots because digestion tears apart protein chains like this. The long form also joined a blood protein and stayed for days [2]. Those details still don’t give you a safe amount, safe mixing steps, or any way for you to know how your body would react.
What did researchers do before each CJC-1295 shot?
The drug has four changed protein building blocks called amino acids [2]. Those changes help it resist being broken down. Staff kept the powder cold, mixed it with water that holds down germ growth, and gave the shot below the skin [1]. Those steps describe the study, not safe home care for you.
Why can’t these studies set a human dose?
Only a few people took part in the early human work. One 2006 study and another 2006 study checked hormones, not whether people lived better or stayed safe for years [1][3]. ConjuChem was the drug company behind a Phase 2 trial, an early study of possible help and harm, in people with deep belly fat tied to HIV.
The company stopped that trial and ended its whole effort before a large study answered the key questions [1]. Without that work, any dose is a guess. I wouldn’t turn what one study gave into advice for your body, because the amount wasn’t chosen for you and it isn’t your prescription.